Dietmar Berger, M.D., Ph.D.
Senior Vice President and Global Head, Product Development, Clinical Hematology and Oncology, Roche/Genentech
Dr. Berger leads the medical strategy for global clinical development portfolio for cancer medicines at Roche/Genentech. He was formerly vice president of global clinical development for the company’s HER2 breast cancer franchise and was instrumental in the development and marketing approvals of two breast cancer medicines across three new indications.
Dr. Berger has more than 20 years of experience in oncology research and development, including as head of the clinical research center at the University Medical Hospital, Freiburg, Germany. He has held leadership positions at several global pharmaceutical companies and received the Cancer Award of the German Cancer Society for his research on angiogenesis. Dr. Berger has authored more than 40 scientific publications and five books.